Article
The Cell Killing Mechanisms of Hydroxyurea
17 Nov 2016
Abstract excerpt
Hydroxyurea is a well-established inhibitor of ribonucleotide reductase that has a long history of scientific interest and clinical use for the treatment of neoplastic and non-neoplastic diseases. It is currently the staple drug for the management of sickle cell anemia and chronic myeloproliferative disorders. Due to its reversible inhibitory effect on DNA replication in various organisms, hydroxyurea is also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
